M4MM

Compass Pathways Advances Psilocybin Research in the UK

LOS ANGELES- Compass Pathways, a biotechnology company specializing in mental health innovations, has commenced the UK segment of its global Phase 3 clinical trial evaluating COMP360 psilocybin therapy for treatment-resistant depression (TRD). This initiative follows ...

Compass Pathways Advances Psilocybin Research in the UK

LOS ANGELES- Compass Pathways, a biotechnology company specializing in mental health innovations, has commenced the UK segment of its global Phase 3 clinical trial evaluating COMP360 psilocybin therapy for treatment-resistant depression (TRD). This initiative follows ...

The Valens Company Enters Flower, Pre-Roll Categories

KELOWNA, BC–The Valens Company (TSX: VLNS) (OTCQX: VLNCF), a manufacturer of cannabis products, today announced that it has launched several new products in partnership with Verse Cannabis in the flower, pre-roll, concentrates, and edibles categories. With ...

Subscribe To Our Newsletter